OverviewChartNewsTraderScreen

BVT Call 55 BMY 20.09.2024/  DE000VM8N6L6  /

Frankfurt Zert./VONT
6/28/2024  10:34:40 AM Chg.+0.001 Bid10:34:40 AM Ask10:34:40 AM Underlying Strike price Expiration date Option type
0.008EUR +14.29% 0.008
Bid Size: 55,000		 0.020
Ask Size: 55,000		 Bristol Myers Squibb... 55.00 USD 9/20/2024 Call
GlobeNewswire 6/27 Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 M...
GlobeNewswire 6/27 Purple Biotech Reports Additional Positive Interim Results from its Randomized Phase 2 Pancreatic Ca...
GlobeNewswire 6/26 Intellia Therapeutics Announces CFO Transition
GlobeNewswire 6/19 Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Re...
GlobeNewswire 6/19 CSE is hosting in New York City the Sustainability & ESG Leadership Summit
GlobeNewswire 6/18 CytomX Therapeutics to Present at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Confere...
GlobeNewswire 6/17 CytomX Therapeutics Promotes Chris Ogden to Chief Financial Officer
GlobeNewswire 6/17 Acute Myeloid Leukemia Market Size Expected to Reach $2.97 Billion By 2029 as Clinical Trials Increa...
GlobeNewswire 6/17 Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angel...
GlobeNewswire 6/14 Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...
GlobeNewswire 6/12 Crossject appoints Dan Chiche, MD as Chief Medical Officer North America
GlobeNewswire 6/11 Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
GlobeNewswire 6/11 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 6/11 Allyx Therapeutics Announces First Alzheimer’s Disease Patient Treated with Lead Compound ALX-001
GlobeNewswire 6/10 RenovoRx Appoints Ryan Witt as Senior Vice President, Head of Corporate Strategy and Partnerships
GlobeNewswire 6/10 C4 Therapeutics Appoints Ron Cooper as Chairman of the Board of Directors
GlobeNewswire 5/31 Immunocore reports updated Phase 1 data of brenetafusp (IMC-F106C), an ImmTAC bispecific targeting P...
GlobeNewswire 5/30 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 5/24 Recursion Appoints Robert Hershberg M.D., Ph.D, as New Chair of the Board
GlobeNewswire 5/23 Corporate Employers Accused of Increasing Risk Of Pension Shortfalls in Violation of Employee Retire...
GlobeNewswire 5/23 Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire 5/22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
GlobeNewswire 5/22 Anavex Life Sciences Announces Expansion of Leadership Team
GlobeNewswire 5/16 CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire 5/15 Lantheus Announces Executive Appointments to Accelerate Innovation